ALDX | Aldeyra Therapeutics Inc
Category: Consumer goods
Quick infos Headquarters: Lexington, Massachusetts, United States Trade prices Volume: Market Cap: 221.55M Prev closed: 12.07 Open: 12 High: 12.63 Low: 11.86 52 week low: 1.48 52 week high: 14.62 Dividends: Next ER: March 9, 2023 Before Market Opens
Earnings History Date EPS / Forecast Revenue / Forecast May 11, 2023 March 9, 2023 -0.22 / -0.3126- / -November 10, 2022 -0.25 / -0.34- / -August 5, 2022 -0.3 / -0.3108- / -May 5, 2022 -0.29 / -0.315- / -view more
Historical Data Date Price Open High Low Vol Change ER Jul 13, 2022 5.24 4.95 5.55
4.89
2.24M 1.95% Jul 12, 2022 5.14 4.59 5.25
4.26
3.95M 14.99% Jul 11, 2022 4.47 4.50 4.59
4.45
540.01K -0.45% Jul 8, 2022 4.49 4.24 4.51
4.22
743.07K 3.46% Jul 7, 2022 4.34 4.21 4.43
4.19
477.59K 4.58% Jul 6, 2022 4.15 4.03 4.29
4.02
551.32K 2.98% Jul 5, 2022 4.03 3.73 4.05
3.68
541.38K 6.05% Jul 1, 2022 3.80 3.97 4.07
3.75
579.70K -4.76% Jun 30, 2022 3.99 3.81 4.04
3.81
565.82K 1.53% Jun 29, 2022 3.93 3.96 4.01
3.81
655.63K -1.5% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Aldeyra Therapeutics GAAP EPS of -$0.25 beats by $0.10 seekingalpha.com Nov 10, 2022 8:02 pm Aldeyra Therapeutics Q3 2022 Earnings Preview seekingalpha.com Nov 10, 2022 2:32 am Aldeyra stock rises as eye disorder drug ADX-2191 meets main goal in part 1 of phase 3 trial seekingalpha.com Oct 6, 2022 8:02 pm Aldeyra Therapeutics (ALDX) Q4 2020 Earnings Call Transcript nasdaq.com Mar 13, 2021 3:11 am Aldeyra Therapeutics on track to submit new drug application for dry eye disease treatment seekingalpha.com Sep 14, 2022 10:17 pm Aldeyra Therapeutics stock rises 13% on Q2 beat with eyes on approval path for reproxalap seekingalpha.com Aug 6, 2022 12:21 am Aldeyra Therapeutics GAAP EPS of -$0.30 beats by $0.02 seekingalpha.com Aug 5, 2022 7:05 pm Aldeyra says trial for dry eye disease candidate reached key goals seekingalpha.com Jul 12, 2022 7:29 pm Aldeyra stock soars as dry eye disease drug meets main goal in late stage study seekingalpha.com Jun 8, 2022 8:00 pm Aldeyra says post-hoc analysis shows its eye therapy reduced ocular redness seekingalpha.com May 18, 2022 8:55 pm Aldeyra Therapeutics GAAP EPS of -$0.29 beats by $0.04 seekingalpha.com May 5, 2022 7:19 pm Aldeyra Therapeutics Q1 2022 Earnings Preview seekingalpha.com May 5, 2022 2:14 am Aldeyra Therapeutics CFO steps down, interim CFO appointed seekingalpha.com Apr 29, 2022 4:21 am Mid-stage trials show proof of concept for Aldeyra immune-mediated disease candidate seekingalpha.com Mar 29, 2022 8:59 pm Aldeyra Therapeutics GAAP EPS of -$1.07 beats by $0.02 seekingalpha.com Mar 17, 2022 7:01 pm Aldeyra Therapeutics starts phase 2 trial of ADX-2191 to treat rare eye disorders seekingalpha.com Mar 9, 2022 12:05 am Aldeyra reports positive top-line data from Phase 2 reproxalap study in dry eye disease seekingalpha.com Jan 11, 2022 9:38 pm Aldeyra Therapeutics completes enrollment in part 1 of phase 3 study of eye disorder drug seekingalpha.com Jan 5, 2022 12:50 am Aldeyra defended at Citi despite setback to dry eye disease study for reproxalap seekingalpha.com Dec 22, 2021 1:26 am Aldeyra crashes on setback to dry eye disease study for reproxalap seekingalpha.com Dec 21, 2021 5:26 am Key Persons Chairman : Chairperson: Richard H. Douglas CEO : Todd C. Brady M.D., Ph.D. Talk about Aldeyra Therapeutics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?
